Henry Schein (HSIC) Stock Price
Henry Schein Price
Over the last 19 years Henry Schein grew revenue by 5.1% annually, reaching 13.18 B USD. Earnings per share have grown at 6.5% per year over the last 19 years. For Henry Schein, the net margin of 3.0% is down versus 5.0% a few years ago. The consensus 12-month price target for Henry Schein is 94.50 USD, about 12.3% above where the stock trades today. Of 25 analysts, 15 rate the stock a buy — an overall Buy consensus.
Henry Schein stock price
Henry Schein business model & stock analysis
Frequently asked questions about Henry Schein
The business model of Henry Schein Inc revolves around being a leading provider of healthcare products and services. With a focus on the dental, veterinary, and medical industries, Henry Schein offers a wide range of products, equipment, and technology solutions to healthcare professionals worldwide. The company's business model emphasizes delivering value, quality, and innovation to its customers. Through strategic partnerships, efficient distribution channels, and a strong customer-centric approach, Henry Schein Inc aims to support healthcare providers in delivering optimal patient care while driving growth and profitability for the company.
Henry Schein Inc is primarily active in the healthcare industry.
The main competitors of Henry Schein Inc in the market include Patterson Companies Inc and Benco Dental Supply Company.
Henry Schein Inc is a leading healthcare solutions provider, catering to both healthcare professionals and manufacturers. Founded in 1932 by Henry Schein and his wife Esther, the company began as a small storefront distributing dental supplies. Over the years, it has grown into a global corporation, offering a wide range of products and services in the dental, animal health, and medical sectors. Henry Schein Inc is committed to enhancing patient care through innovative solutions, advanced technology, and comprehensive support. With a rich history spanning nearly a century, Henry Schein Inc has established itself as a trusted name in the healthcare industry, serving customers in over 190 countries.
Henry Schein Inc, a renowned company in the healthcare industry, has achieved significant milestones throughout its history. Being one of the largest distributors of healthcare products and services, Henry Schein has established itself as a global leader. Some notable achievements include expanding its reach to over 90 countries worldwide, consistently ranking on the Fortune 500 list, and generating billions in revenue annually. Additionally, the company has received numerous accolades for its exemplary corporate social responsibility efforts and commitment to sustainability. With a strong focus on innovation and customer satisfaction, Henry Schein Inc continues to make strides in improving healthcare outcomes and shaping the future of the industry.
Henry Schein Inc is primarily present in multiple countries and regions worldwide. Some of the major markets where the company operates include the United States, Canada, Europe, Australia, New Zealand, and parts of Asia. With its global presence, Henry Schein Inc serves various healthcare professionals and institutions, offering a wide range of products and services in the dental, medical, and animal health sectors. With a strong focus on delivering comprehensive solutions, Henry Schein Inc has established itself as a trusted provider in the healthcare industry across these countries and regions.
Henry Schein Inc is a leading healthcare company that values integrity, innovation, and service excellence. The company's corporate philosophy revolves around enabling healthcare professionals to deliver quality care to patients through enhanced practice management, advanced technology, and superior distribution capabilities. With a focus on building trust and fostering strong relationships, Henry Schein Inc aims to empower healthcare providers by providing them with the tools and resources they need to succeed. By upholding high ethical standards and striving for continuous improvement, Henry Schein Inc is committed to making a positive impact in the healthcare industry.
Analysts currently set an average price target of 90.80 USD for the Henry Schein stock (median: 94.50 USD), implying +7.9 % versus the latest price. The consensus is based on 25 analyst ratings.
25 analysts currently rate the Henry Schein stock: 15 recommend buying, 9 holding and 1 selling. For 2026, analysts expect Henry Schein to generate revenue of 13.87 B USD and earnings per share of 5.23 USD.
Converted at the current exchange rate, the Henry Schein share trades at 75.11 EUR (84.17 USD).
The Henry Schein share (HSIC) is listed on 10 stock exchanges, including: NASDAQ (HSIC), London (0L3C.L), SIX (Zürich) (HSIC.SW), XETRA (HS2.DE), Frankfurt (HS2.F), München (HS2.MU), Düsseldorf (HS2.DU), Hamburg (HS2.HM).
Henry Schein, Inc. is a global provider of health solutions and services for clinic and dental partners. The company has been in operation for over 87 years and is headquartered in Melville, New York. Henry Schein's business model focuses on four main segments: dental products, medical products, veterinary products, and practice management and consulting services. Each segment offers a variety of products and services tailored to the needs of doctors, dentists, and veterinarians. In the dental field, Henry Schein offers a comprehensive range of products such as instruments, equipment, dental materials and accessories, intraoral cameras, X-ray machines and films, and digital impression systems. The company also works closely with dentists by providing training and continuing education programs that enhance practice management skills and help expand patient base. In the medical field, Henry Schein offers a wide range of products including medications, medical instruments, practice supplies, laboratory chemicals, and diagnostics. The company also provides a variety of services such as support in setting up practice management systems, the e-clinic program to support telemedicine and digitization of medical records. Additionally, they also have a veterinary division that provides products and services for veterinarians. This includes animal medications, diagnostics, and surgical instruments. The company also offers veterinary management software to assist veterinarians in managing their practices and patients. Finally, the company offers practice management and consulting services aimed at increasing profitability and efficiency for medical, dental, and veterinary practices. They provide the solution for practice software for billing, appointment scheduling, and integration of patient data as well as training for staff. Henry Schein places strong emphasis on customer retention and support to promote company growth through a range of marketing and sales programs. This includes product offerings, in-depth training for product users, and effective consultations for practice and business strategy. The company is also expanding its presence on social media to reach new customers and engage existing ones. Overall, Henry Schein focuses on innovative and effective solutions to meet the needs of its customers in the healthcare industry. The company strives to offer a diverse and comprehensive range of products and services, aiming to provide customers with compactness and efficiency in their daily work.
The expected revenue of Henry Schein is 13.87 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Henry Schein is 618.73 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Henry Schein is currently 16.10. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Henry Schein stock.
The price-to-sales ratio (P/S) of Henry Schein is currently 0.72. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Henry Schein stock.
The Eulerpool Quality Score for Henry Schein is 4/10.
The ISIN of Henry Schein is US8064071025. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Henry Schein is 897961. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Henry Schein is HSIC. The ticker symbol is used to trade Henry Schein shares on the stock exchange.
Henry Schein stock
Henry Schein Peer Group
Henry Schein Ticker
Henry Schein FIGI
All fundamentals and in-depth analysis of Henry Schein
Our stock analysis for Henry Schein stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Henry Schein. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.